The interferon (IFN) system is an important physiological defense mechanism against virus infections, and apparently has other biological functions. IFN action on cells must begin with an interaction with cellular receptors which must initiate a chain of events leading to the development of the antiviral and other responses. However, little is known about the IFN receptors, and the events initiated by the IFN receptor interaction. We have demonstrated by binding and crosslinking studies with human cells that ?125?I-labeled human IFN-alpha?2? (cloned in E. coli) binds to a specific macromolecule (Mr = 130,000) which appears to be the receptor for human IFN-alpha (and IFN-beta) or a component (e.g., the IFN-binding subunit) of it. Studies are planned to characterize the IFN-alpha/beta receptor by biochemical analyses: e.g., to determine whether the receptor is a monomeric or a multimeric molecule, and if the latter, its subunit composition; whether the receptor is a glycoprotein, and if so, whether its carbohydrate component is important for the IFN binding or the development of the cellular response; for example, by testing whether the receptors are susceptible to treatment with neuraminidase and glycosidases or inhibitors of protein glycosylation. We will carry out experiments to solubilize the receptor for fractionation and partial purification, and attempt to raise antibodies against it. We will screen human cell lines which have the IFN-alpha/beta receptors but are insensitive to IFN. Study of the lesion in such cell lines may provide important information regarding the IFN mechanism. Experiments will be carried out to explore the events that follow the IFN receptor interaction, for example, to study the internalization and sub-cellular localization of the internalized IFN and IFN-receptor complex in relation to the development of the cellular response, and to test for covalent modifications such as protein phosphorylation and ADP-ribosylation (as in the case of certain hormones and toxins). These studies would reveal the biochemical characteristics of the IFN receptor system, and provide some necessary information pertaining to the early events initiated by the IFN receptor interaction on the cell surface. (HF)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA029991-05
Application #
3168935
Study Section
Cognition and Perception Study Section (CP)
Project Start
1980-09-11
Project End
1987-04-30
Budget Start
1985-05-01
Budget End
1986-04-30
Support Year
5
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Chon, S Y; Hassanain, H H; Gupta, S L (1996) Cooperative role of interferon regulatory factor 1 and p91 (STAT1) response elements in interferon-gamma-inducible expression of human indoleamine 2,3-dioxygenase gene. J Biol Chem 271:17247-52
Chon, S Y; Hassanain, H H; Pine, R et al. (1995) Involvement of two regulatory elements in interferon-gamma-regulated expression of human indoleamine 2,3-dioxygenase gene. J Interferon Cytokine Res 15:517-26
Najfeld, V; Menninger, J; Muhleman, D et al. (1993) Localization of indoleamine 2,3-dioxygenase gene (INDO) to chromosome 8p12-->p11 by fluorescent in situ hybridization. Cytogenet Cell Genet 64:231-2
Hassanain, H H; Dai, W; Gupta, S L (1993) Enhanced gel mobility shift assay for DNA-binding factors. Anal Biochem 213:162-7
Burkin, D J; Kimbro, K S; Barr, B L et al. (1993) Localization of the human indoleamine 2,3-dioxygenase (IDO) gene to the pericentromeric region of human chromosome 8. Genomics 17:262-3
Hassanain, H H; Chon, S Y; Gupta, S L (1993) Differential regulation of human indoleamine 2,3-dioxygenase gene expression by interferons-gamma and -alpha. Analysis of the regulatory region of the gene and identification of an interferon-gamma-inducible DNA-binding factor. J Biol Chem 268:5077-84
Feng, G S; Dai, W; Gupta, S L et al. (1991) Analysis of interferon-gamma resistant mutants that are possibly defective in their signaling mechanism. Mol Gen Genet 230:91-6
Dai, W; Gupta, S L (1990) Molecular cloning, sequencing and expression of human interferon-gamma-inducible indoleamine 2,3-dioxygenase cDNA. Biochem Biophys Res Commun 168:1-8
Dai, W; Gupta, S L (1990) Regulation of indoleamine 2,3-dioxygenase gene expression in human fibroblasts by interferon-gamma. Upstream control region discriminates between interferon-gamma and interferon-alpha. J Biol Chem 265:19871-7
Gupta, S L (1990) Regulation of cellular gene expression by interferon-gamma: involvement of multiple pathways. Int J Cell Cloning 8 Suppl 1:92-102

Showing the most recent 10 out of 14 publications